Chun-yu Jin

Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity

T. Qu, T. Zhong, Baiyong Li, 2022, Journal for immunotherapy of cancer.

Abstract 5526: AK131, an anti-PD1/CD73 bispecific antibody for cancer immune therapy

T. Zhong, Baiyong Li, Zhao-liang Huang, 2022, Cancer Research.

AK119, A CD73 TARGETING ANTIBODY WITH DUAL MECHANISM OF ACTION

T. Zhong, D. Xia, Z. Wang, 2021 .